TY - JOUR
T1 - Insulinopathies of the brain? Genetic overlap between somatic insulin-related and neuropsychiatric disorders
AU - Fanelli, G.
AU - Franke, B.
AU - De Witte, W.
AU - Ruisch, I.H.
AU - Haavik, J.
AU - van Gils, V.
AU - Jansen, W.J.
AU - Vos, S.J.B.
AU - Lind, L.
AU - Buitelaar, J.K.
AU - Banaschewski, T.
AU - Dalsgaard, S.
AU - Serretti, A.
AU - Mota, N.R.
AU - Poelmans, G.
AU - Bralten, J.
N1 - Funding Information:
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 847879 (PRIME, Prevention and Remediation of Insulin Multimorbidity in Europe). Nina Roth Mota was supported by the European Union’s Horizon 2020 Programme (H2020/2014 – 2020) under grant agreement No. 667302 (CoCA) and by funding for the Dutch National Science Agenda NeurolabNL project (grant 400‐17‐602). Janita Bralten was supported by a personal grant from the Netherlands Organization for Scientific Research (NWO) Innovation Program (Veni grant No. 09150161910091). The analyses were carried out on the Dutch national e-infrastructure, part of the research programme Computing Time National Computing Facilities Processing Round pilots 2018 with project No. 17666, which is (partly) financed by the NWO. We also thank the researchers of the consortia that provided the GWAS summary statistics used in our analyses and the participants of the cohorts to which they refer.
Funding Information:
This project has received funding from the European Union?s Horizon 2020 research and innovation programme under grant agreement No. 847879 (PRIME, Prevention and Remediation of Insulin Multimorbidity in Europe). Nina Roth Mota was supported by the European Union?s Horizon 2020 Programme (H2020/2014 ? 2020) under grant agreement No. 667302 (CoCA) and by funding for the Dutch National Science Agenda NeurolabNL project (grant 400?17?602). Janita Bralten was supported by a personal grant from the Netherlands Organization for Scientific Research (NWO) Innovation Program (Veni grant No. 09150161910091). The analyses were carried out on the Dutch national e-infrastructure, part of the research programme Computing Time National Computing Facilities Processing Round pilots 2018 with project No. 17666, which is (partly) financed by the NWO. We also thank the researchers of the consortia that provided the GWAS summary statistics used in our analyses and the participants of the cohorts to which they refer.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/2/14
Y1 - 2022/2/14
N2 - The prevalence of somatic insulinopathies, like metabolic syndrome (MetS), obesity, and type 2 diabetes mellitus (T2DM), is higher in Alzheimer's disease (AD), autism spectrum disorder (ASD), and obsessive-compulsive disorder (OCD). Dysregulation of insulin signalling has been implicated in these neuropsychiatric disorders, and shared genetic factors might partly underlie this observed multimorbidity. We investigated the genetic overlap between AD, ASD, and OCD with MetS, obesity, and T2DM by estimating pairwise global genetic correlations using the summary statistics of the largest available genome-wide association studies for these phenotypes. Having tested these hypotheses, other potential brain "insulinopathies" were also explored by estimating the genetic relationship of six additional neuropsychiatric disorders with nine insulin-related diseases/traits. Stratified covariance analyses were then performed to investigate the contribution of insulin-related gene sets. Significant negative genetic correlations were found between OCD and MetS (r(g) = -0.315, p = 3.9 x 10(-8)), OCD and obesity (r(g) = -0.379, p = 3.4 x 10(-5)), and OCD and T2DM (r(g) = -0.172, p = 3 x 10(-4)). Significant genetic correlations with insulin-related phenotypes were also found for anorexia nervosa (AN), attention-deficit/hyperactivity disorder (ADHD), major depressive disorder, and schizophrenia (p < 6.17 x 10(-4)). Stratified analyses showed negative genetic covariances between AD, ASD, OCD, ADHD, AN, bipolar disorder, schizophrenia and somatic insulinopathies through gene sets related to insulin signalling and insulin receptor recycling, and positive genetic covariances between AN and T2DM, as well as ADHD and MetS through gene sets related to insulin processing/secretion (p < 2.06 x 10(-4)). Overall, our findings suggest the existence of two dusters of neuropsychiatric disorders, in which the genetics of insulin-related diseases/traits may exert divergent pleiotropic effects. These results represent a starting point for a new research line on "insulinopathies" of the brain.
AB - The prevalence of somatic insulinopathies, like metabolic syndrome (MetS), obesity, and type 2 diabetes mellitus (T2DM), is higher in Alzheimer's disease (AD), autism spectrum disorder (ASD), and obsessive-compulsive disorder (OCD). Dysregulation of insulin signalling has been implicated in these neuropsychiatric disorders, and shared genetic factors might partly underlie this observed multimorbidity. We investigated the genetic overlap between AD, ASD, and OCD with MetS, obesity, and T2DM by estimating pairwise global genetic correlations using the summary statistics of the largest available genome-wide association studies for these phenotypes. Having tested these hypotheses, other potential brain "insulinopathies" were also explored by estimating the genetic relationship of six additional neuropsychiatric disorders with nine insulin-related diseases/traits. Stratified covariance analyses were then performed to investigate the contribution of insulin-related gene sets. Significant negative genetic correlations were found between OCD and MetS (r(g) = -0.315, p = 3.9 x 10(-8)), OCD and obesity (r(g) = -0.379, p = 3.4 x 10(-5)), and OCD and T2DM (r(g) = -0.172, p = 3 x 10(-4)). Significant genetic correlations with insulin-related phenotypes were also found for anorexia nervosa (AN), attention-deficit/hyperactivity disorder (ADHD), major depressive disorder, and schizophrenia (p < 6.17 x 10(-4)). Stratified analyses showed negative genetic covariances between AD, ASD, OCD, ADHD, AN, bipolar disorder, schizophrenia and somatic insulinopathies through gene sets related to insulin signalling and insulin receptor recycling, and positive genetic covariances between AN and T2DM, as well as ADHD and MetS through gene sets related to insulin processing/secretion (p < 2.06 x 10(-4)). Overall, our findings suggest the existence of two dusters of neuropsychiatric disorders, in which the genetics of insulin-related diseases/traits may exert divergent pleiotropic effects. These results represent a starting point for a new research line on "insulinopathies" of the brain.
KW - OBSESSIVE-COMPULSIVE DISORDER
KW - ALZHEIMERS-DISEASE
KW - METABOLIC SYNDROME
KW - MENTAL-DISORDERS
KW - BIPOLAR DISORDER
KW - SCHIZOPHRENIA
KW - ASSOCIATION
KW - AUTISM
KW - RISK
U2 - 10.1038/s41398-022-01817-0
DO - 10.1038/s41398-022-01817-0
M3 - Article
C2 - 35165256
SN - 2158-3188
VL - 12
JO - Translational Psychiatry
JF - Translational Psychiatry
IS - 1
M1 - 59
ER -